Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice

Casitas B-Lineage Lymphoma b Inhibits Antigen Recognition and Slows Cell Cycle Progression at Late Times during CD4+ T Cell Clonal Expansion

(2014) R. Zhang et al.   JOURNAL OF IMMUNOLOGY

Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene

(2009) Taimei Yang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Adoptive T cell therapy of cancer

(2009) Ton NM Schumacher et al.   CURRENT OPINION IN IMMUNOLOGY

The E3 Ubiquitin Ligase Cbl-b Regulates Expansion but Not Functional Activity of Self-Reactive CD4 T Cells

(2009) M.-C. St. Rose et al.   JOURNAL OF IMMUNOLOGY

Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells

(2009) Ye Zhang et al.   JOURNAL OF PATHOLOGY

Adoptive Immunotherapy of Disseminated Leukemia With TCR-transduced, CD8+ T Cells Expressing a Known Endogenous TCR

(2009) Michelle L Dossett et al.   MOLECULAR THERAPY

Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies

(2009) Marc Pellegrini et al.   NATURE MEDICINE

Molecular regulation of T-cell anergy

(2008) Yan Zheng et al.   EMBO REPORTS

Peripheral CD8+ T Cell Tolerance to Self-Proteins Is Regulated Proximally at the T Cell Receptor

(2008) Ryan M. Teague et al.   IMMUNITY

T-Cell Receptor-Induced NF- B Activation Is Negatively Regulated by E3 Ubiquitin Ligase Cbl-b

(2008) G. Qiao et al.   MOLECULAR AND CELLULAR BIOLOGY